Silence Therapeutics reported $62.3M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
AstraZeneca USD 48.67B 2.78B Dec/2025
Autolus Therapeutics Ltd USD 265.45M 81.01M Sep/2025
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Novartis USD 46.13B 1.38B Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
Silence Therapeutics USD 62.3M 11.76M Dec/2025